KYLE WIKTOR: Open Payments
NPI 1326030495 · WARSAW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 35 payments from 11 companies in 2025. Trend: 2023 $72 · 2024 $314 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $217 |
| Indivior Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Alkermes, Inc. | 2 | $32 |
| Corium, LLC | 3 | $25 |
Products named: VRAYLAR, SUBLOCADE, Auvelity, UZEDY, INGREZZA, CAPLYTA, FANAPT, ARISTADA.
Industry payments across NY — which companies pay providers there.
